Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit

By Sabrina Valle, Mrinalika Roy and Tom Hals (Reuters) -Pfizer filed a second lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for Metsera to stall the entry of the biotech firm's treatments into the obesity drug market rather than being aimed at closing a deal. Novo and Metsera on Monday rejected Pfizer's claims, which were a dramatic escalation in the fight for control of the biotech startup. A judge will analyze the complaints on Tuesday. Pfizer agreed to pay ...